These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 12455069)
1. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069 [No Abstract] [Full Text] [Related]
2. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. International Collaboration on HIV and Cancer J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. Rabkin CS; Testa MA; Huang J; Von Roenn JH J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216 [TBL] [Abstract][Full Text] [Related]
4. The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma. Clayton G; Omasta-Martin A; Bower M J HIV Ther; 2006 Sep; 11(3):51-3. PubMed ID: 17580498 [No Abstract] [Full Text] [Related]
5. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma]. Gabarre J; Bossi P Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765 [TBL] [Abstract][Full Text] [Related]
6. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta. Gingues S; Gill MJ HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981 [TBL] [Abstract][Full Text] [Related]
7. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. Ledergerber B; Telenti A; Egger M BMJ; 1999 Jul; 319(7201):23-4. PubMed ID: 10390454 [No Abstract] [Full Text] [Related]
9. Impact of HAART on HIV-linked malignancies. Laurence J AIDS Read; 2003 May; 13(5):202, 205. PubMed ID: 12800820 [No Abstract] [Full Text] [Related]
10. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
11. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003]. Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104 [TBL] [Abstract][Full Text] [Related]
12. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. Ives NJ; Gazzard BG; Easterbrook PJ J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320 [TBL] [Abstract][Full Text] [Related]
13. AIDS malignancies in the era of highly active antiretroviral therapy. Gates AE; Kaplan LD Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534 [TBL] [Abstract][Full Text] [Related]
14. AIDS related malignant disease at regional institute of medical sciences. Gatphoh ED; Zamzachin G; Devi SB; Punyabati P Indian J Pathol Microbiol; 2001 Jan; 44(1):1-4. PubMed ID: 12561985 [TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies. Campanini A; Marani M; Mastroianni A; Cancellieri C; Vicini C Acta Otorhinolaryngol Ital; 2005 Feb; 25(1):30-5. PubMed ID: 16080313 [TBL] [Abstract][Full Text] [Related]
16. Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Infection Study Group. Johnson CC; Wilcosky T; Kvale P; Rosen M; Stansell J; Glassroth J; Reichman L; Wallace J; Markowitz N; Thompson JE; Hopewell P Am J Epidemiol; 1997 Sep; 146(6):470-5. PubMed ID: 9290507 [TBL] [Abstract][Full Text] [Related]
17. CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK. Bower M; Fisher M; Hill T; Reeves I; Walsh J; Orkin C; Phillips AN; Bansi L; Gilson R; Easterbrook P; Johnson M; Gazzard B; Leen C; Pillay D; Schwenk A; Anderson J; Porter K; Gompels M; Sabin CA; Haematologica; 2009 Jun; 94(6):875-80. PubMed ID: 19336735 [TBL] [Abstract][Full Text] [Related]
18. HIV-associated malignancies in children. Mueller BU AIDS Patient Care STDS; 1999 Sep; 13(9):527-33. PubMed ID: 10813032 [TBL] [Abstract][Full Text] [Related]
19. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. Engels EA; Goedert JJ J Natl Cancer Inst; 2005 Mar; 97(6):407-9. PubMed ID: 15769998 [No Abstract] [Full Text] [Related] [Next] [New Search]